Análisis de la cuota de mercado y oportunidades de los medicamentos para el estreñimiento inducido por opioides (2025-2031)
Opioid Induced Constipation Drugs Market Report Analysis
Opioid Induced Constipation Drugs Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- AstraZeneca plc.
- Mallinckrodt Pharmaceuticals
- Salix Pharmaceuticals Inc.
- Merck & Co Inc.
- Shionogi & Co Ltd.
- Ironwood Pharmaceutical Inc.
- Pfizer
- Progenics Pharmaceuticals Inc.
- Nektar Therapeutics
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Tipo de fármaco
- bromuro de metilnaltrexona
- lubiprostona
- naloxegol
- naldemedina
- docusato de sodio
- otros
By Tipo de receta
- medicamentos recetados
- medicamentos de venta libre
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For